Retatrutide

Weight Loss

Chemical Information:

• Chemical Name: Retatrutide
• Compound Type: Synthetic triple agonist peptide (GLP-1 + GIP + GCG)
• Molecular Formula: C₂₃₅H₃₆₁N₆₃O₇₂ (approximate; varies with specific peptide modifications)
• Molecular Weight: ~4,400–4,500 g/mol
• Peptide Class: Next-generation triple agonist peptide, designed for enhanced metabolic and weight-loss research

Description:

Retatrutide peptide is a next-generation triple agonist peptide that simultaneously targets GLP-1, GIP, and glucagon (GCG) receptors. Designed for advanced metabolic research, it modulates appetite, enhances satiety, promotes fat loss, improves glycemic control, and increases energy expenditure. By engaging multiple hormonal pathways, Retatrutide supports investigations into obesity, type 2 diabetes, and cardiometabolic disorders. Its potent multi-receptor activity makes it ideal for laboratory or physician-supervised research exploring next-generation therapeutic strategies for weight management and metabolic optimization.

Research Applications:

• Appetite and Satiety Studies: Investigating multi-hormonal regulation of food intake, meal patterns, and satiety signaling through GLP-1, GIP, and glucagon pathways.
• Metabolic and Energy Regulation: Exploring effects on energy expenditure, fat oxidation, and glucose homeostasis for obesity and metabolic research.
• Glycemic Control Research: Studying impact on insulin secretion, insulin sensitivity, and blood sugar management in preclinical or clinical research settings.
• Obesity and Multi-Pathway Therapeutics: Assessing potential synergistic effects of triple agonism for next-generation weight-loss interventions and cardiometabolic health studies.

Storage and Handling:

• Store at –20°C; short-term storage at 2–8°C is acceptable.
• Protect from light and keep vials tightly sealed.
• Use aseptic techniques and avoid repeated freeze-thaw cycles.

Product Specifications:

• Purity: ≥98% (HPLC certified)
• Appearance: White to off-white lyophilized powder
• Solubility: Soluble in sterile water, DMSO, or other polar solvents suitable for peptide research

Compliance Notice:

Retatrutide peptide is intended strictly for research and clinical investigation purposes and is not approved for human or veterinary use. This product has not been evaluated by the FDA or any other regulatory authority. Any unauthorized use is prohibited and may be subject to applicable laws. By purchasing, the buyer acknowledges that Retatrutide will be used solely for controlled laboratory or physician-supervised research studies.